Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
08 2019
Historique:
received: 17 12 2018
revised: 03 04 2019
accepted: 18 04 2019
pubmed: 7 5 2019
medline: 31 3 2020
entrez: 7 5 2019
Statut: ppublish

Résumé

Achromatopsia (ACHM) is a hereditary cone photoreceptor disorder characterized by the inability to discriminate colors, nystagmus, photophobia, and low-visual acuity. Six genes have been associated with this rare autosomal recessively inherited disease, including the GNAT2 gene encoding the catalytic α-subunit of the G-protein transducin which is expressed in the cone photoreceptor outer segment. Out of a cohort of 1,116 independent families diagnosed with a primary clinical diagnosis of ACHM, we identified 23 patients with ACHM from 19 independent families with likely causative mutations in GNAT2, representing 1.7% of our large ACHM cohort. In total 22 different potentially disease-causing variants, of which 12 are novel, were identified. The mutation spectrum also includes a novel copy number variation, a heterozygous duplication of exon 4, of which the breakpoint matches exactly that of the previously reported exon 4 deletion. Two patients carry just a single heterozygous variant. In addition to our previous study on GNAT2-ACHM, we also present detailed clinical data of these patients.

Identifiants

pubmed: 31058429
doi: 10.1002/humu.23768
doi:

Substances chimiques

Heterotrimeric GTP-Binding Proteins EC 3.6.5.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1145-1155

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01GM0850
Pays : International
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GM1108A
Pays : International
Organisme : Raregenomics (Consejeria de Edicacion de la Comunidad de Madrid)
Pays : International
Organisme : Medical Faculty of the University of Tuebingen
Pays : International
Organisme : The European Reference Network dedicated to Rare Eye Diseases (ERN-EYE)
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB430
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : KFO134
Pays : International
Organisme : FEDER (European Regional Development Fund)
Pays : International
Organisme : CIBERER
ID : 06/07/0036
Pays : International
Organisme : FIS
ID : PI16/00425
Pays : International
Organisme : PRO RETINA foundation
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Julia Felden (J)

Institute for Ophthalmic Research, Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

Britta Baumann (B)

Institute for Ophthalmic Research, Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

Manir Ali (M)

Section of Ophthalmology and Neuroscience, Leeds Institute of Medical Research at St. James's University Hospital, University of Leeds, Leeds, England.

Isabelle Audo (I)

Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institute de la Vision/ CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS, Paris, France.

Carmen Ayuso (C)

University Hospital Fundación Jiménez Díaz/Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.

Beatrice Bocquet (B)

Centre de Référence Maladies Sensorielles Génétiques, Hôpital Gui de Chauliac; Montpellier University and INSERM U1051, Institute for Neurosciences of Montpellier, Montpellier, France.

Ingele Casteels (I)

Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.

Blanca Garcia-Sandoval (B)

Department of Ophthalmology, Fundación Jimenez Diaz University Hospital, Madrid, Spain.

Samuel G Jacobson (SG)

Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Bernhard Jurklies (B)

Helios Clinics Wuppertal, Wuppertal, Germany.

Ulrich Kellner (U)

Rare Retinal Disease Center, AugenZentrum Siegburg, MVZ ADTC Siegburg GmbH, Europaplatz 3, Siegburg, Germany.

Line Kessel (L)

The National Eye Clinic, Rigshospitalet, Kennedy Center, Glostrup, Denmark.
Department of Clinical Medicine, University of Copenhagen, Denmark.

Birgit Lorenz (B)

Department of Ophthalmology, Justus-Liebig-University Giessen, Giessen, Germany.

Martin McKibbin (M)

Section of Ophthalmology and Neuroscience, Leeds Institute of Medical Research at St. James's University Hospital, University of Leeds, Leeds, England.

Isabelle Meunier (I)

Centre de Référence Maladies Sensorielles Génétiques, Hôpital Gui de Chauliac; Montpellier University and INSERM U1051, Institute for Neurosciences of Montpellier, Montpellier, France.

Thomy de Ravel (T)

Center for Human Genetics, University Hospitals Leuven, University of Leuven, Leuven, Belgium.

Thomas Rosenberg (T)

The National Eye Clinic, Rigshospitalet, Kennedy Center, Glostrup, Denmark.
Department of Clinical Medicine, University of Copenhagen, Denmark.

Klaus Rüther (K)

Augenarztpraxis, Dorotheenstrasse 56, Berlin, Germany.

Maria Vadala (M)

Ophthalmology Institute, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata (BiND), Università degli Studi di Palermo.

Bernd Wissinger (B)

Institute for Ophthalmic Research, Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

Katarina Stingl (K)

University Eye Hospital, Center for Ophthalmology, University of Tübingen, Germany.

Susanne Kohl (S)

Institute for Ophthalmic Research, Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH